樂觀
$137.73
情境價格
$238.710
+2.292 (+0.96%)收盤時
Plexus Corp. is engaged in providing design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services. The Company's design and development capabilities include product strategy, product development, design for excellence (DFX), and test engineering. Its new product introduction capabilities include DFX, transition management, test engineering, supply chain management, and rapid prototype. Its manufacturing capabilities include end-to-end manufacturing, integrated test and inspection, fulfillment and logistics. Its supply chain capabilities include early engagement and early engagement. Its sustaining service capabilities include distribution management, product life cycle extension, aftermarket services, repair and refurbishment. It serves the aerospace, defense, security, space, advanced surgical systems, medical robotics, life sciences, diagnostics, medical devices and equipment sectors.
Plexus Corp is currently priced at $230.47, which is significantly below several analyst price targets, including $300 from KeyBanc and $330 from Stifel. However, the stock has seen a recent decline of 12.22% over the past five days and has an RSI of 12.338, indicating it may be oversold. The upcoming earnings report on October 28 could provide a catalyst for recovery, but the recent insider selling (up 1088.24%) raises concerns about confidence in the stock. Given these mixed signals, it may be prudent to hold rather than buy at this moment.
KeyBanc
$300
2026-09-21
KeyBanc
2026-09-21
目標價
$300
Sidoti
$308
2026-07-31
Sidoti
2026-07-31
目標價
$308
Stifel
$330
2026-06-22
Stifel
2026-06-22
目標價
$330
Needham
$310
2026-06-01
Needham
2026-06-01
目標價
$310
Stifel
$280
2026-05-01
Stifel
2026-05-01
目標價
$280
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Plexus to Release Q4 and FY 2026 Earnings Results

Keybanc Upgrades Plexus to Overweight Rating

Latest Wall Street Ratings and Price Target Analysis

Plexus Executive Sells 500 Shares of Stock

Plexus Director Sells 500 Shares of Stock
Plexus Corp. is engaged in providing design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services. The Company's design and development capabilities include product strategy, product development, design for excellence (DFX), and test engineering. Its new product introduction capabilities include DFX, transition management, test engineering, supply chain management, and rapid prototype. Its manufacturing capabilities include end-to-end manufacturing, integrated test and inspection, fulfillment and logistics. Its supply chain capabilities include early engagement and early engagement. Its sustaining service capabilities include distribution management, product life cycle extension, aftermarket services, repair and refurbishment. It serves the aerospace, defense, security, space, advanced surgical systems, medical robotics, life sciences, diagnostics, medical devices and equipment sectors. It operates in the Technology sector (PRINTED CIRCUIT BOARDS industry).
Plexus Corp is currently priced at $230.47, which is significantly below several analyst price targets, including $300 from KeyBanc and $330 from Stifel. However, the stock has seen a recent decline of 12.22% over the past five days and has an RSI of 12.338, indicating it may be oversold. The upcoming earnings report on October 28 could provide a catalyst for recovery, but the recent insider selling (up 1088.24%) raises concerns about confidence in the stock. Given these mixed signals, it may be prudent to hold rather than buy at this moment.
8 analysts cover PLXS: 1 rate it Buy, 6 Hold and 1 Sell. The average price target is 208.67.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。